Efendic; Suad

Patent Applications and Registrations

Patent applications and USPTO patent grants for Efendic; Suad.The latest application filed is for "somatostatin receptor antagonists and glucose control or hypoglycemia".

Company Profile

0.12.16

Efendic; Suad - Lindingo SE
Efendic; Suad - Lidingo SE
Efendic; Suad - 18134 Lidingo SE
Efendic; Suad - Linding o SE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Somatostatin receptor antagonists and glucose control or hypoglycemia Grant 8,206,722 - Vranic , et al. June 26, 2	2012-06-26
Somatostatin Receptor Antagonists and Glucose Control or Hypoglycemia App 20110064742 - Vranic; Mladen ; et al.	2011-03-17
Method of controlling tight blood glucose by somatostatin receptor antagonists Grant 7,862,825 - Vranic , et al. January 4, 2	2011-01-04
Somatostatin Receptor Antagonists And Glucose Control Or Hypoglycemia App 20090004195 - Vranic; Mladen ; et al.	2009-01-01
Methods for identifying compounds for treating diabetes mellitus Grant 7,381,523 - Efendic June 3, 2	2008-06-03
Method of reducing mortality and morbidity associated with critical illnesses App 20080032932 - Jakubowski; Joseph Anthony ; et al.	2008-02-07
Use Of Glp-1 Or Analogs In Treatment Of Myocardial Infarction App 20080009433 - Efendic; Suad	2008-01-10
Use of a peptide App 20070225212 - Efendic; Suad ; et al.	2007-09-27
Use Of Glp-1 Analogs And Derivatives Administered Peripherally In Regulation Of Obesity App 20070173452 - DiMarchi; Richard ; et al.	2007-07-26
Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity Grant 7,211,557 - DiMarchi , et al. May 1, 2	2007-05-01
Methods for identifying compounds for treating diabetes mellitus App 20070003986 - Efendic; Suad	2007-01-04
Use of a peptide App 20060247174 - Efendic; Suad ; et al.	2006-11-02
Use of GLP-1 or analogs in treatment of stroke App 20060160740 - Efendic; Suad	2006-07-20
Methods for identifying compounds for treating diabetes mellitus App 20050287557 - Efendic, Suad	2005-12-29
Glucagon-like peptides (glp-1) and treatment of respiratory distress App 20040235726 - Jakubowski, Joseph Anthony ; et al.	2004-11-25
Use of GLP-1 or analogs in treatment of myocardial infarction App 20040162241 - Efendic, Suad	2004-08-19
Use of GLP-1 or analogs in treatment of myocardial infarction Grant 6,747,006 - Efendic June 8, 2	2004-06-08
Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity App 20040018975 - DiMarchi, Richard ; et al.	2004-01-29
Use of GLP-1 analogs and derivative adminstered peripherally in regulation of obesity Grant 6,583,111 - DiMarchi , et al. June 24, 2	2003-06-24
Use of a peptide App 20030083259 - Efendic, Suad ; et al.	2003-05-01
Use of GLP-1 or analogs in treatment of myocardial infarction App 20030022823 - Efendic, Suad	2003-01-30
Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein Grant 6,348,447 - Hellstrom , et al. February 19, 2	2002-02-19
Use of GLP-1 or analogs in treatment of myocardial infarction Grant 6,277,819 - Efendic August 21, 2	2001-08-21
Peptide Grant RE37,302 - Efendic , et al. July 31, 2	2001-07-31
Use of a peptide App 20010002394 - Efendic, Suad ; et al.	2001-05-31
Use of GLP-1 analogs and derivatives administered peripherally in regulation of obesity Grant 6,191,102 - DiMarchi , et al. February 20, 2	2001-02-20
Use of GLP-1 or analogs to abolish catabolic changes after surgery Grant 6,006,753 - Efendic December 28, 1	1999-12-28
Use of a peptide Grant 5,631,224 - Efendic , et al. May 20, 1	1997-05-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.